Medical device company Medtronic is cutting 2,000 jobs worldwide due to slow growth, with about half of the layoffs affecting U.S. workers. The company is currently facing legal trouble for its Medtronic Infuse Bone Graft device, which patients say has caused harm.
The Medtronic Infuse Bone Graft is a cage-like metal device that is used to spur bone growth in the lower spine. The Food and Drug Administration approved the device to be inserted through the abdomen or lower back, but the company allegedly promoted off-label usage of the Infuse in the upper back.
By 2008, more than 300 patients had complained of severe Infuse Bone Graft side effects from the unapproved procedure, including excessive bone growth, male sterility, retrograde ejaculation, swelling and death. Medtronic is facing Infuse bone graft lawsuits alleging the company illegally promoted the device for unapproved procedures.